Long-Term Prognosis of Stage I Ovarian Carcinoma
- 1 July 2003
- journal article
- research article
- Published by S. Karger AG in Oncology
- Vol. 65 (1) , 29-36
- https://doi.org/10.1159/000071202
Abstract
Objective: There are a few long-term follow-up studies of patients with stage I ovarian carcinoma. The objective of this study was to evaluate prognostic factors for long-term survival. Methods: Two hundred fourteen stage I ovarian carcinomas (registered by the Tokai Ovarian Tumor Study Group from 1988 to 1999) were analyzed. Staging according to the International Federation of Gynecology and Obstetrics was set without considering the pathologic findings of the lymph nodes. Stage Ic was divided into Ic(b) and other Ic. Results: Seventy-four patients were stage Ia, 2 were stage Ib, and 138 were stage Ic, consisting of 75 Ic(b) and 63 other Ic patients. The ratios of stage Ic to Ia and stage Ic(b) to Ic were highest in clear-cell adenocarcinoma among histologies analyzed. There were significant differences in disease-free survival curves between each group. In clear cell adenocarcinoma, there was a significant difference in disease- free survival curves between stage Ic(b) and other Ic (p = 0.0373), while this tendency was also observed in other histologies except for mucinous carcinoma. Multivariate analysis demonstrated that substage was a significant prognostic factor of both disease-free and overall survival. Conclusions: Stage Ic(b) patients showed poorer survival than stage Ia patients but better than survival in other Ic. Thus, cautious treatment of ovarian tumor during surgery is quite important to avoid rupture.Keywords
This publication has 12 references indexed in Scilit:
- Identification of Prognostic Factors in Advanced Epithelial Ovarian CarcinomaGynecologic Oncology, 2001
- Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaThe Lancet, 2001
- Randomized Trial of Cisplatin and Carboplatin versus Cisplatin, Vinblastine and Bleomycin in Ovarian CancerGynecologic and Obstetric Investigation, 2000
- Long-Term Results and Prognostic Factors in Patients with Epithelial Ovarian CancerGynecologic Oncology, 2000
- Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian CancerGynecologic Oncology, 1999
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- The Prognostic Significance of Residual Disease, FIGO Substage, Tumor Histology, and Grade in Patients with FIGO Stage III Ovarian CancerGynecologic Oncology, 1995
- Different types of rupture of the tumor capsule and the impact on survival in early ovarian carcinomaInternational Journal of Gynecologic Cancer, 1994
- Clear Cell Epithelial Ovarian Cancer (Mesonephroid): Bad Prognosis Only in Early StagesGynecologic Oncology, 1993
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992